Table 1 Baseline characteristics.
Characteristic | Penicillin n = 12 | Ceftriaxone n = 12 | p |
|---|---|---|---|
Age, median years | 42 (33-57) | 40.5 (29-47) | 0,38 |
Follow-up, median months | 38,3 (5.5-73) | 11.5 (1.5-78.5) | 0.13 |
CD4+ T cell counts, median cells/μl | 264 (128-849) | 411 (24-707) | 0.08 |
HAART, n = 7 | 7 | ||
Baseline VDRL, median | 1:32 | 1:64-1:128 | 0.23 |
Early syphilis n = | 11 of 12 (92%) | 9 of 12 (75%) | 0.59 |
stage I | 2 | 1 | |
stage II | 6 | 6 | |
Early latent | 3 | 2 | |
Neurosyphilis n = | 1 | 2 | |
Probably late latent, unknown duration, n= | 0 | 1 | |
Clinical signs at presentation, n= | 9 of 12 (75%) | 7 of 12 (58%) | 0.66 |
Reinfection, n = 2 | 0 | ||
possible reactivation, n = | 0 | 2 | |
documented seroconversion, n = | 6 of 12 (50%) | 4 of 12 (33%) | 0.68 |
lumbar puncture, n = | 2 | 4 |